Partisan Management Group

Communication Science, Inc. was founded in 1989 to provide kits of medical supplies and instructions for patients to self-treat various medical conditions. The key competency of Careguide is the use of ethnography to develop and perfect medical instructions. Over time, Careguide has focused on chronic diseases and has completed a series of clinical studies demonstrating a pronounced increase in compliance and a major reduction in medical costs associated with the use of the Company's kits. Partisan principals and related entities have invested $1.4 million in Careguide

Ash Access Technology, Inc. is an integrated specialty pharmaceutical / medical device company engaged in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company has an advanced portfolio of innovative products targeting catheter-related bloodstream infections (CRBSI) and poor patency (blood flow) - the significant challenges associated with the use of both acute and chronic catheters for vascular access.

Medivance, Inc. develops, manufactures, and sells temperature management products to hospitals worldwide. The company’s flagship product, the Arctic Sun Temperature Management System, enables clinicians to manage patient temperature in a noninvasive manner. It also offers clinical training in Targeted Temperature Management. The company was founded in 1998 and is headquartered in Louisville, Colorado with a European office in Den Hague, the Netherlands. As of November 10, 2011, Medivance, Inc. operates as a subsidiary of Bard Medical, Inc.

Medivance, Inc. develops, manufactures, and sells temperature management products to hospitals worldwide. The company’s flagship product, the Arctic Sun Temperature Management System, enables clinicians to manage patient temperature in a noninvasive manner. It also offers clinical training in Targeted Temperature Management. The company was founded in 1998 and is headquartered in Louisville, Colorado with a European office in Den Hague, the Netherlands. As of November 10, 2011, Medivance, Inc. operates as a subsidiary of Bard Medical, Inc.

Enable Injections, LLC develops a disposable body-worn bolus injector to deliver high viscosity/volume payloads to the subcutaneous tissue. The company’s system uses standard vial, syringe, or cartridge container closure; and automatically mixes lyophilized solutions. Its drug delivery system’s transfer package automatically warms the drug, and enables user to insert the container into the system, place the injector on the skin, and press the central button, as well as know the progress of the delivery through its viewing window, and then dispose the device. It also offers partial or multi-vial/syringe transfer systems for filling its LVWIs. The company was founded in 2010 and is based in Cincinnati, Ohio.

Ponce De Leon Health, Inc, a development stage company, develops a formulation comprised of generally regarded as safe (GRAS) components. Its formulation targets to increase mean lifespan in the invertebrate model (C. Elegans). The company was incorporated in 2015 and is based in Drogheda, Ireland.

Headquartered near Cincinnati, Ohio, AtriCure has assembled experts in the medical device industry to form a highly effective team dedicated to serving patients, medical professionals, and investors.

Surefire Medical, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The Surefire's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, which collapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.

Ash Access Technology, Inc. is an integrated specialty pharmaceutical / medical device company engaged in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company has an advanced portfolio of innovative products targeting catheter-related bloodstream infections (CRBSI) and poor patency (blood flow) - the significant challenges associated with the use of both acute and chronic catheters for vascular access.

Surefire Medical, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The Surefire's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, which collapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.

Enable Injections, LLC develops a disposable body-worn bolus injector to deliver high viscosity/volume payloads to the subcutaneous tissue. The company’s system uses standard vial, syringe, or cartridge container closure; and automatically mixes lyophilized solutions. Its drug delivery system’s transfer package automatically warms the drug, and enables user to insert the container into the system, place the injector on the skin, and press the central button, as well as know the progress of the delivery through its viewing window, and then dispose the device. It also offers partial or multi-vial/syringe transfer systems for filling its LVWIs. The company was founded in 2010 and is based in Cincinnati, Ohio.

Surefire Medical, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The Surefire's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, which collapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.

Enable Injections, LLC develops a disposable body-worn bolus injector to deliver high viscosity/volume payloads to the subcutaneous tissue. The company’s system uses standard vial, syringe, or cartridge container closure; and automatically mixes lyophilized solutions. Its drug delivery system’s transfer package automatically warms the drug, and enables user to insert the container into the system, place the injector on the skin, and press the central button, as well as know the progress of the delivery through its viewing window, and then dispose the device. It also offers partial or multi-vial/syringe transfer systems for filling its LVWIs. The company was founded in 2010 and is based in Cincinnati, Ohio.

ZS Pharma is a privately held specialty pharmaceutical company based in Coppell, Texas, and Menlo Park, CA. Its core focus is the research and development of highly selective ion-trap therapies to treat serious medical conditions. The company'ss therapeutic candidate, ZS-9, is a novel treatment for hyperkalemia, a life-threatening condition that affects patients with chronic kidney disease, hypertension, diabetes, and/or chronic heart failure. Hyperkalemia is characterized by abnormally high concentrations of potassium in the blood. ZS-9 is currently being tested in late-stage clinical trials.

Zurex Pharmacy is a specialty pharmacy and medical technology company with a novel antimicrobial technology platform. Their company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare-acquired infections with a focus on surgical site wounds and catheter-related infections. It was founded in 2010 and is headquartered in Middleton, Wisconsin.

Headquartered near Cincinnati, Ohio, AtriCure has assembled experts in the medical device industry to form a highly effective team dedicated to serving patients, medical professionals, and investors.

Communication Science, Inc. was founded in 1989 to provide kits of medical supplies and instructions for patients to self-treat various medical conditions. The key competency of Careguide is the use of ethnography to develop and perfect medical instructions. Over time, Careguide has focused on chronic diseases and has completed a series of clinical studies demonstrating a pronounced increase in compliance and a major reduction in medical costs associated with the use of the Company's kits. Partisan principals and related entities have invested $1.4 million in Careguide

Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. The company was founded in 2003 and is based in Malvern, Pennsylvania.

Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. The company was founded in 2003 and is based in Malvern, Pennsylvania.

Preceptis Medical is a medical device manufacturer developing surgical tools that allow ear tube procedures to be performed with reduced pain and surgical time for the pediatric patient. Its pediatric surgical technology Hummingbird TTS offers an alternative to general anesthesia and minimizes surgical trauma during ear tube placement, enabling physicians to use moderate sedation for routine ear tube procedures. Preceptis Medical was founded in 2011 and is headquartered in Maple Grove, Minnesota.

Enable Injections, LLC develops a disposable body-worn bolus injector to deliver high viscosity/volume payloads to the subcutaneous tissue. The company’s system uses standard vial, syringe, or cartridge container closure; and automatically mixes lyophilized solutions. Its drug delivery system’s transfer package automatically warms the drug, and enables user to insert the container into the system, place the injector on the skin, and press the central button, as well as know the progress of the delivery through its viewing window, and then dispose the device. It also offers partial or multi-vial/syringe transfer systems for filling its LVWIs. The company was founded in 2010 and is based in Cincinnati, Ohio.

Ponce De Leon Health, Inc, a development stage company, develops a formulation comprised of generally regarded as safe (GRAS) components. Its formulation targets to increase mean lifespan in the invertebrate model (C. Elegans). The company was incorporated in 2015 and is based in Drogheda, Ireland.

Preceptis Medical is a medical device manufacturer developing surgical tools that allow ear tube procedures to be performed with reduced pain and surgical time for the pediatric patient. Its pediatric surgical technology Hummingbird TTS offers an alternative to general anesthesia and minimizes surgical trauma during ear tube placement, enabling physicians to use moderate sedation for routine ear tube procedures. Preceptis Medical was founded in 2011 and is headquartered in Maple Grove, Minnesota.

Surefire Medical, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The Surefire's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, which collapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.

ZS Pharma is a privately held specialty pharmaceutical company based in Coppell, Texas, and Menlo Park, CA. Its core focus is the research and development of highly selective ion-trap therapies to treat serious medical conditions. The company'ss therapeutic candidate, ZS-9, is a novel treatment for hyperkalemia, a life-threatening condition that affects patients with chronic kidney disease, hypertension, diabetes, and/or chronic heart failure. Hyperkalemia is characterized by abnormally high concentrations of potassium in the blood. ZS-9 is currently being tested in late-stage clinical trials.